B-R-A-H-M-S’ Submits Congestive Heart Failure Test to FDA
B-R-A-H-M-S Aktiengesellschaft announces that it has submitted 510(k) file to the FDA to market its patented B-R-A-H-M-S MR-proANP Kryptor Test.
Read MorePosted by Clinical Lab Products | Mar 9, 2009 | Miscellaneous |
B-R-A-H-M-S Aktiengesellschaft announces that it has submitted 510(k) file to the FDA to market its patented B-R-A-H-M-S MR-proANP Kryptor Test.
Read MorePosted by Clinical Lab Products | Feb 6, 2009 | Cancer, Miscellaneous |
The world in vitro diagnostic test market won’t be stalled by economic conditions for a variety of reasons, according to Kalorama Information.
Read MorePosted by Clinical Lab Products | Jan 13, 2009 | Miscellaneous |
A new national study has shown that nearly 75% of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk for a cardiovascular event.
Read MorePosted by Clinical Lab Products | Aug 11, 2008 | Cancer, Miscellaneous |
Prostate cancer diagnosis tends to be delayed and surgical treatment more difficult in obese men than in lean men, according to two recently published studies.
Read MorePosted by Clinical Lab Products | Jun 23, 2008 | Diabetes & Metabolic Diseases |
Bio-Rad Laboratories Inc, Hercules, Calif, has introduced the new Bio-Plex Pro human diabetes assay panels for its Bio-Plex suspension-array system.
Read More